Overall, these results collectively demonstrate two future possibilities to amerliorate GNAQ/11-induced uveal melanoma; reduction of Gαq/11-Q209L driver oncoprotein levels through Ric-8A inhibition or phorbol ester treatment. This evidence concerns the gene RIC8A and uveal melanoma.